Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Srushti Mahajan

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
AAPS Pharmscitech|November 5, 2024
The Neoteric Paradigm of Biomolecule-Functionalized Albumin-Based Targeted Cancer TherapeuticsSwati Gunjkar, Ujala Gupta, Rahul Nair, et al.
International Journal of Biological Macromolecules|September 11, 2025
Hyaluronic acid driven biomimetic nanoparticles loaded CDK4/6 inhibitor for effective targeted breast cancer therapyUjala Gupta, Samata Pradhan, Omkar Dhage, et al.
Journal of Biomolecular Structure & Dynamics|June 5, 2023
Acalabrutinib as a novel hope for the treatment of breast and lung cancer: an in-silico proof of conceptKedar Khaparkhuntikar, Indrani Maji, Sunil Kumar Gupta, et al.
AAPS Pharmscitech|November 4, 2021
Budding Multi-matrix Technology-a Retrospective Approach, Deep Insights, and Future PerspectivesAnitha Sriram, Suma Tangirala, Srividya Atmakuri, et al.
ACS Applied Bio Materials|August 25, 2025
Chondroitin Sulfate-Mediated Targeted Delivery of Docetaxel and Silibinin-Loaded Nanoparticles for Amelioration of Anticancer Efficacy in Breast CancerMayur Aalhate, Srushti Mahajan, Rahul Kumar, et al.
Drug Delivery and Translational Research|April 17, 2023
Self-nanoemulsifying drug delivery system (SNEDDS) of docetaxel and carvacrol synergizes the anticancer activity and enables safer toxicity profile: optimization, and in-vitro, ex-vivo and in-vivo pharmacokinetic evaluationMohd Aman Mohd Ateeq, Mayur Aalhate, Srushti Mahajan, et al.
Journal of Materials Chemistry. B|May 22, 2025
Benchmarking of pH-responsive mixed micelles for repurposed breast cancer therapy of ibrutinib with molecular modeling and pharmacokinetic insightsIndrani Maji, Sharon Munagalasetty, Lakshmi Tulasi Naraharisetti, et al.
Drug Delivery and Translational Research|May 4, 2023
Correction to: Self-nanoemulsifying drug delivery system (SNEDDS) of docetaxel and carvacrol synergizes the anticancer activity and enables safer toxicity profile: optimization, and in-vitro, ex-vivo and in-vivo pharmacokinetic evaluationMohd Aman Mohd Ateeq, Mayur Aalhate, Srushti Mahajan, et al.
International Journal of Biological Macromolecules|November 8, 2025
Bovine serum albumin capped lipid nanosystem bearing CDK4/6 inhibitor to combat breast cancer: In-vitro and In-vivo assessmentMayur Aalhate, Srushti Mahajan, Rahul Kumar, et al.
Therapeutic Delivery|September 17, 2024
Solid Self Nano-Emulsifying Drug Delivery System of Dasatinib: Optimization, <i>In-vitro</i>, <i>Ex-vivo</i> and <i>In-vivo</i> assessmentMohd Aman Mohd Ateeq, Srushti Mahajan, Brojendra Nath Saren, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
AAPS Pharmscitech|November 5, 2024
The Neoteric Paradigm of Biomolecule-Functionalized Albumin-Based Targeted Cancer TherapeuticsSwati Gunjkar, Ujala Gupta, Rahul Nair, et al.
International Journal of Biological Macromolecules|September 11, 2025
Hyaluronic acid driven biomimetic nanoparticles loaded CDK4/6 inhibitor for effective targeted breast cancer therapyUjala Gupta, Samata Pradhan, Omkar Dhage, et al.
Journal of Biomolecular Structure & Dynamics|June 5, 2023
Acalabrutinib as a novel hope for the treatment of breast and lung cancer: an in-silico proof of conceptKedar Khaparkhuntikar, Indrani Maji, Sunil Kumar Gupta, et al.
AAPS Pharmscitech|November 4, 2021
Budding Multi-matrix Technology-a Retrospective Approach, Deep Insights, and Future PerspectivesAnitha Sriram, Suma Tangirala, Srividya Atmakuri, et al.
ACS Applied Bio Materials|August 25, 2025
Chondroitin Sulfate-Mediated Targeted Delivery of Docetaxel and Silibinin-Loaded Nanoparticles for Amelioration of Anticancer Efficacy in Breast CancerMayur Aalhate, Srushti Mahajan, Rahul Kumar, et al.
Drug Delivery and Translational Research|April 17, 2023
Self-nanoemulsifying drug delivery system (SNEDDS) of docetaxel and carvacrol synergizes the anticancer activity and enables safer toxicity profile: optimization, and in-vitro, ex-vivo and in-vivo pharmacokinetic evaluationMohd Aman Mohd Ateeq, Mayur Aalhate, Srushti Mahajan, et al.
Journal of Materials Chemistry. B|May 22, 2025
Benchmarking of pH-responsive mixed micelles for repurposed breast cancer therapy of ibrutinib with molecular modeling and pharmacokinetic insightsIndrani Maji, Sharon Munagalasetty, Lakshmi Tulasi Naraharisetti, et al.
Drug Delivery and Translational Research|May 4, 2023
Correction to: Self-nanoemulsifying drug delivery system (SNEDDS) of docetaxel and carvacrol synergizes the anticancer activity and enables safer toxicity profile: optimization, and in-vitro, ex-vivo and in-vivo pharmacokinetic evaluationMohd Aman Mohd Ateeq, Mayur Aalhate, Srushti Mahajan, et al.
International Journal of Biological Macromolecules|November 8, 2025
Bovine serum albumin capped lipid nanosystem bearing CDK4/6 inhibitor to combat breast cancer: In-vitro and In-vivo assessmentMayur Aalhate, Srushti Mahajan, Rahul Kumar, et al.
Therapeutic Delivery|September 17, 2024
Solid Self Nano-Emulsifying Drug Delivery System of Dasatinib: Optimization, <i>In-vitro</i>, <i>Ex-vivo</i> and <i>In-vivo</i> assessmentMohd Aman Mohd Ateeq, Srushti Mahajan, Brojendra Nath Saren, et al.
Pageof 4